This inventor holds 3 USPTO granted patents. Top assignees: Smithkline Beecham Corporation, Other. Active years: 2000-2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 2,198 
1 out of 834,513 Years Active: 2000-2001
Title: Karen M Anderson: Innovator in Serum Inducible Kinase Research
Introduction
Karen M Anderson is a notable inventor based in West Chester, PA (US). She has made significant contributions to the field of biochemistry, particularly in the study of serum inducible kinases. With a total of 3 patents to her name, her work has implications for therapeutic and diagnostic applications.
Latest Patents
Among her latest patents is the development of the Serum Inducible Kinase (Snk) polypeptides and polynucleotides. This patent discloses methods for producing such polypeptides through recombinant techniques. Additionally, it outlines methods for utilizing Serum Inducible Kinase (Snk) polypeptides and polynucleotides in therapy, as well as diagnostic assays for their application.
Career Highlights
Throughout her career, Karen has worked with prominent organizations, including SmithKline Beecham Corporation. Her innovative research has paved the way for advancements in therapeutic techniques and diagnostic methods.
Collaborations
Karen has collaborated with esteemed colleagues such as Sandhya S Nerurkar and Amy K Roshak. These partnerships have further enriched her research and contributed to her success in the field.
Conclusion
Karen M Anderson's contributions to the field of serum inducible kinases highlight her role as a leading inventor in biochemistry. Her patents and collaborations reflect her commitment to advancing medical science and improving therapeutic outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile